Health disparities and bias in clinical research cost Europe 1.4% of GDP every year
The lack of equitable health care it doesn't just depend on wealth. During the pandemic in the United States, for...
The lack of equitable health care it doesn't just depend on wealth. During the pandemic in the United States, for...
The full transition to clinical recommendations for the provision of medical care is actually postponed until 2026, the association of...
The hope that pharmaceutical companies from China and India will replace modern drugs from Western manufacturers on the Russian market...
Along with the gradual withdrawal of international pharmaceutical holdings from the clinical research market, foreign contract research companies (CROs) also...
While international pharmaceutical manufacturers have noticeably reduced clinical trials of drugs in Russia, the R-Pharm company founded by Alexey Repik...
Despite statements by international pharmaceutical companies about the suspension of new trials in Russia after the outbreak of hostilities in...
As an analysis by Kommersant showed, over the three quarters of 2023, Russian pharmaceutical manufacturers received 12% more approvals for...
Advanced BioDesign, a Lyon-based biotechnology company specializing in the development of a new family of targeted therapies in oncology, has...
Foreign pharmaceutical companies have practically ceased to receive permissions to conduct clinical trials (CTs) of new original drugs: in the...
(Penang, 24th) Haoyang Health Food Industry Co., Ltd. and the University of Science Malaysia have cooperated to launch an 18-month...
In Russia, clinical trials of drugs are being reduced: in 2022, the Ministry of Health issued 18.5% fewer permits than...